Showing results (921-930 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|June 17, 2000
Proteasome inhibition: a new strategy in cancer treatmentJ Adams, V J Palombella, P J ElliottInvestigational New Drugs|June 17, 2000
A phase II pilot study of KW-2189 in patients with advanced renal cell carcinomaE J Small, R Figlin, D Petrylak, et al.Investigational New Drugs|June 17, 2000
A phase II trial of topotecan in esophageal carcinoma: a Southwest Oncology Group study (SWOG 9339)J S Macdonald, J L Jacobson, S J Ketchel, et al.Investigational New Drugs|May 11, 2002
A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group studyRobert P Whitehead, Joseph M Unger, Lawrence E Flaherty, et al.Investigational New Drugs|May 11, 2002
Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group studySarah A Taylor, Cathryn Rankin, Jeannette J Townsend, et al.Investigational New Drugs|May 11, 2002
The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group studyJames K Weick, John J Crowley, Mohamed A Hussein, et al.Investigational New Drugs|May 11, 2002
Preclinical efficacy evaluations of XK-469: dose schedule, route and cross-resistance behavior in tumor bearing miceLisa Polin, Kathryn White, Juiwanna Kushner, et al.Investigational New Drugs|May 11, 2002
Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipateOlga V Leontieva, Maria N Preobrazhenskaya, Ralph J BernackiInvestigational New Drugs|July 9, 2002
Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancerMatthew R Smith, Philip W KantoffPageof 372